Source Citation
Joseph P, Roshandel G, Gao P, et al. Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis. Lancet. 2021;398:1133-46. https://pubmed.ncbi.nlm.nih.gov/34469765
Clinical Impact Ratings
GIM/FP/GP: 
Cardiology:
References
- 1. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13-115. [PMID:
29133356 ] Google Scholar - 2. Teo K, Yusuf S. Polypill variants (quarter pill trials). Am J Hypertens. 2018;31:758-61. [PMID:
29554202 ] Google Scholar - 3. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326:1419. [PMID:
12829553 ] Google Scholar - 4. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953-2041. [PMID:
30234752 ] Google Scholar
